Reuters
The researchers tested a vaccine that protects women against two strains of the human papillomavirus (HPV) which are linked to more than 70 percent of cervical cancer cases. The vaccine was developed by drugs giant GlaxoSmithKline Plc.
"This is the first time we have shown that there is a vaccine that protects against the only cause of a cancer and we can actually prevent 70 percent of all cervical cancer worldwide," said Diane Harper, of Dartmouth Medical School in New Hampshire.
More...
|